World first: gene therapy trial for rare disease patient

A patient at BHP’s Queen Elizabeth Hospital Birmingham (QEHB) has become the first person in the world to take part in a pioneering gene therapy trial for his rare disease. Simon Smith, 45, was diagnosed with Ornithine Transcarbamylase (OTC) deficiency as a teenager.   Although he defied medical expectations by living a full life in … Continue reading “World first: gene therapy trial for rare disease patient”

Birmingham paediatric cardiology study identifies key research priorities

Cardiology experts from Birmingham Health Partners have led the first national study into identifying research priorities for patients diagnosed with single-ventricle heart conditions. Single-ventricle heart conditions occur in about 2 to 3 in every 10,000 births, and typically children have to undergo three or more open heart surgeries before school age, culminating in the Fontan … Continue reading “Birmingham paediatric cardiology study identifies key research priorities”

Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies. The funding has been provided as part of the Industrial Strategy Challenge Fund’s Medicines Manufacturing programme. Cell and gene therapies … Continue reading “Birmingham to lead ground-breaking research into patient experience of cell therapies”

Birmingham to lead brain cancer study in memory of Tessa Jowell

Significant funding of up to £2.8m from The Brain Tumour Charity has been awarded to a Birmingham researcher for a major study named in memory of the late Baroness Jowell. The Tessa Jowell BRAIN-MATRIX trial is being co-ordinated by Professor Colin Watts (pictured) of the Institute of Cancer and Genomic Sciences, part of the University of … Continue reading “Birmingham to lead brain cancer study in memory of Tessa Jowell”

New diabetes drug to be trialled in Birmingham

Researchers from the Diabetes Research Unit and the Clinical Research Facility at the Queen Elizabeth Hospital, Birmingham are currently recruiting patients with type 1 diabetes to a trial for a new drug which could change the future of treatment for the condition. The Birmingham trial will be led by Dr Parth Narendran, together with research … Continue reading “New diabetes drug to be trialled in Birmingham”